SCHEMBL30211679

SCHEMBL30211679

[2H]C1([2H])C(C(=O)OCC)C(=O)CN(Cc2ccc(OC)cc2)C1([2H])[2H]

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.43
KDM4E B2RXH2 8/20 0.43
MAPT P10636 1/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
POLB P06746 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
COMT P21964 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
HPGD P15428 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30211662 0.91 ALDH1A1 (0.43) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL24355064 0.87 ALDH1A1 (0.52) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL9831746 0.87 KDM4E (0.48) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL30211665 0.80 ALDH1A1 (0.51) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL9830344 0.76 S1PR1 (0.46) ALDH1A1KDM4EMEN1KMT2APOLB
SCHEMBL9830753 0.75 ALDH1A1 (0.48) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL30493801 0.75 SIGMAR1 (0.53) KDM4EMEN1KMT2ACOMTHRH3
SCHEMBL9831768 0.74 KDM4E (0.64) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL184071 0.74 MEN1 (0.56) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL183706 0.73 ALDH1A1 (0.52) ALDH1A1KDM4EMEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4153549-A2 RING DEUTERATED GABOXADOL AND ITS USE FOR THE TREATMENT OF PSYCHIATRIC DISORDERS Certego Therapeutics Inc. (US) 2023-03-29 EP disclosed